About this trial
Living with PCD (formerly COVID-PCD) is a participatory research project that aims to answer emerging questions about primary ciliary dyskinesia (PCD) in order to improve the health and quality of life of people with PCD. Persons with confirmed or suspected PCD from anywhere in the world can participate. The study is advertised through patient support groups and participants register online after they read detailed information about the study. Participants receive a detailed questionnaire when they start the study and a follow-up questionnaire (planned once per year). Occasionally, participants receive extra questionnaires focused on special topics. The study is hosted at the University of Bern and recruitment started on May 30th, 2020.
Eligibility criteria
Qualifiers
People of any age with reported suspected or confirmed Primary Ciliary Dyskinesia who gave consent to participate in the study
Disqualifiers
People who report not to have suspected or confirmed Primary Ciliary Dyskinesia
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
University of Bern
Lead sponsor
Selbsthilfegruppe Kartagener Syndrom und Primäre Ciliäre Dyskinesie
Collaborator
Verein Kartagener Syndrom und PCD
Collaborator
PCD Support UK
Collaborator
PCD Foundation
Collaborator
PCD Australia
Collaborator
European Lung Foundation
Collaborator
University of Southampton
Collaborator
Universität Luzern
Collaborator
Associazione Italiana Discinesia Ciliare Primaria Sindrome di Kargagener APS
Collaborator
Asociación Nacional de Pacientes con Discinesia Ciliar Primaria
Collaborator
Association Dyskinésie Ciliaire Primitive ADCP
Collaborator